INTERNATIONAL PATENT: OVID THERAPEUTICS INC. FILES APPLICATION FOR "FUSED PYRIMIDINE COMPOUNDS FOR TREATMENT OF TINNITUS, HEARING LOSS AND MENIERE'S DISEASE"

GENEVA, May 6 -- OVID THERAPEUTICS INC. (441 9th Avenue14th FloorNew York, New York 10001) filed a patent application (PCT/US2025/052178) for "FUSED PYRIMIDINE COMPOUNDS FOR TREATMENT OF TINNITUS, HEARING LOSS, AND MENIERE'S DISEASE" on Oct 23, 2025. With publication no. WO/2026/090360, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHONG, Zhong (441 9th Avenue14th FloorNew York, New York 10001)

Abstract: Methods of treating tinnitus, acute sensorineural hearing loss, age-related hearing loss, or Meniere's disease, with...